Abstract Number: 1787 • ACR/ARP Annual Meeting 2019
The Glucocorticoid-Induced Protein GILZ Represent a Checkpoint in the IFN Program in SLE
Background/Purpose: Given the primacy of Type I interferon (IFN) pathways in SLE pathogenesis, and the near-ubiquity of glucocorticoid (GC) use in SLE treatment, clarifying the…
